Search Results for "Neupro"

14:33 EST 27th November 2014 | BioPortfolio

Matching Channels

None

Matching News

Actavis Confirms Patent Challenge For Generic Neupro

WASHINGTON (dpa-AFX) - Actavis plc (ACT) confirmed Friday that it has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market Rotigotine Ext...

Actavis Confirms Generic Neupro® Patent Challenge

DUBLIN, Aug. 22, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking...

Parkinson's Disease: World Drug Industry and Market 2014-2024

LONDON, June 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Parkinson's Disease: World Drug Industry and Market 2014-2024http://www.reportbuyer.com/pharma_healthcare...

PharmaPoint: Parkinson’s Disease - Global Drug Forecast and Market Analysis to 2022

Recently added to the BioPortfolio report store, PharmaPoint: Parkinson’s Disease - Global Drug Forecast and Market Analysis to 2022 is a new report from GlobalData published on 2014-03-30. This 32...

Promoting the digital dialog

Précis:  Pharma marketing is changing as companies recognize the need to communicate on customers’ own terms. Shaun Holmgreen of UCB explains the ...

The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology"

NEW YORK, July 31, 2014 /PRNewswire/ -- The Galien Foundation today announced the 2014 nominees for the eighth annual Prix Galien USA Awards. The Prix Galien Award is considered the biomedical industr...

Matching PubMed Articles

None

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement